Latest Kaiser Health News Stories
Justices from the right and left ask whether Congress needs to keep its promises.
Health care workers face a greater threat of workplace violence than workers in most other industries. Hospitals are installing security cameras and panic buttons, arming security guards with stun guns and teaching their employees how to handle potentially violent situations.
The chaos and evacuations prompted by wind-fueled wildfire in Sonoma County pose special challenges for people in need of ongoing medical treatment. Volunteer medical personnel have stepped up to provide care and a sense of stability.
Katie West, an American health researcher who has lived in Germany the past three years, hasn’t mastered the language and misses her family. But not having to worry about the cost of her lifesaving medication makes it OK.
A seedy section of downtown Los Angeles has become the go-to place for those who trade in wholesale — and sometimes counterfeit — vaping products. As more people fall ill with a mysterious lung disease linked to e-cigarette use, the manufacture and distribution of vaping products face increased scrutiny.
Even with Germany’s generous universal coverage, sizable health disparities persist between Hamburg’s wealthier and poorer neighborhoods. Two health centers are among those trying to close the gaps.
Unlike in the U.S., health insurance in Germany doesn’t cover birth control. German health advocates say that causes health problems — but change is unlikely.
A hearing before a House Oversight and Reform Committee panel on how to address the crisis of respiratory injuries related to vaping turned surprisingly partisan.
Dentistry in the U.S. can get expensive, even with good insurance. So more people are taking a trip to beautiful Costa Rica to cut the dentistry bill — and perhaps get a tan.
Germany’s pharmacies provide insights into the country’s low drug prices and strict regulations. But they’re still businesses.
People with diabetes say they’ve been waiting for years for better technology to manage their chronic condition. Tired of waiting, some tech-savvy, do-it-yourselfers are constructing their own devices using open-source programming instructions.
A growing number of pregnant women are among the migrants seeking asylum in the United States. Many must wait in Mexico until their cases are heard, spending weeks or months in migrant shelters with limited access to health care.
Hundreds of protesters descended on the state Capitol on Thursday, warning against government tyranny and corporate greed. Their target: not taxes, not high-tech surveillance, but a bill that would determine which kids must get their routine shots.
The Senate Health, Education, Labor and Pensions Committee is scheduled next week to mark up a massive legislative package on curbing health costs, but some of the details remain unresolved, including what formula to use to pay doctors and hospitals involved in surprise medical bills.
At Wednesday’s House Budget Committee, Congressional Budget Office experts outlined the complexities of implementing an overhaul of America’s health insurance system.
During a hearing Tuesday, panel members focused on how drug companies have used patents to allegedly protect their competitive edge and profits.
In an unusual move, the House Rules Committee, instead of one of the panels that typically oversee health policy, held the first House hearing in a decade about converting the U.S. to a government-financed health care system.
Asylum seekers from Mexico and Central America, housed in migrant shelters in the border city of Tijuana, Mexico, are often sick and exhausted from their long journeys. Volunteer health workers from Southern California recently sent a mobile clinic to one of those shelters and spent a day tending to its inhabitants.
During Wednesday’s House subcommittee hearing on insulin price hikes, drug makers and benefits managers pointed fingers at each other for the last decade’s 300% price increase, frustrating congressional representatives.
The Senate Finance Committee’s third drug-pricing hearing focused on pharmacy benefit managers, and was more of a fact-finding mission on how these companies operate than a debate about policy proposals.